GlassScriptPhysician profile
Shari L Senzon
NPI 1518923671
$2,125.12
in general payments reported to CMS, 2019-2025
28 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $167 · 2021: $115 · 2022: $212 · 2023: $372 · 2024: $465 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.13 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Astellas Pharma US INC | $450.27 | 2023-2025 | Veozah |
| Caldera Medical, INC | $175.03 | 2024 | Desara |
| Mayne Pharma Commercial LLC | $151.83 | 2022-2025 | |
| Allergan, INC. | $122.93 | 2019-2020 | |
| Coopersurgical, INC. | $111.40 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $70.73 | 2020-2022 | |
| Organon LLC | $55.63 | 2023 | Nexplanon |
| Exeltis, USA INC. | $54.99 | 2022-2025 | Slynd |
| Baxter Healthcare | $52.58 | 2023 | Tisseel |
| Hologic Sales and Service, LLC | $51.46 | 2023-2025 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Covidien LP | $45.09 | 2020 | |
| Agile Therapeutics, INC. | $37.28 | 2021 | |
| Pfizer INC. | $36.19 | 2023-2024 | |
| Dysis Medical, INC. | $27.21 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $23.80 | 2019 | |
| Sage Therapeutics, LLC | $21.95 | 2024 | |
| Lupin INC. | $20.84 | 2019 | |
| Mylan Pharmaceuticals INC. | $19.51 | 2022 | |
| Daiichi Sankyo INC. | $19.28 | 2019 | |
| Evofem Biosciences, INC. | $17.40 | 2020 | |
| Millicent US INC | $16.22 | 2019 | |
| Mission Pharmacal Company | $15.51 | 2019 | |
| Duchesnay USA Incorporated | $15.39 | 2019 | |
| Myovant Sciences INC. | $15.36 | 2021 | |
| Merck Sharp & Dohme LLC | $14.85 | 2019 | |
| Exact Sciences Corporation | $13.93 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Senzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.